Growth Metrics

Solid Biosciences (SLDB) Non-Current Assets (2017 - 2026)

Quarterly results put Non-Current Assets at $26.1 million for Q1 2026, down 14.4% from a year ago — trailing twelve months through Mar 2026 was $26.1 million (down 14.4% YoY), and the annual figure for FY2025 was $27.1 million, down 13.64%.

Solid Biosciences has reported Non-Current Assets over the past 10 years, most recently at $26.1 million for Q1 2026.

  • Non-Current Assets reached $26.1 million in Q1 2026 per SLDB's latest filing, down from $27.1 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $40.6 million in Q4 2022 and bottomed at $8.9 million in Q1 2022.
  • Median Non-Current Assets over the past 5 years was $33.4 million (2024), compared with a mean of $32.1 million.
  • The largest annual shift saw Non-Current Assets dropped 18.54% in 2022 before it surged 335.67% in 2023.
  • Over 5 years, Non-Current Assets stood at $40.6 million in 2022, then fell by 13.32% to $35.2 million in 2023, then decreased by 10.92% to $31.4 million in 2024, then dropped by 13.64% to $27.1 million in 2025, then dropped by 3.61% to $26.1 million in 2026.
  • Business Quant data shows Non-Current Assets for SLDB at $26.1 million in Q1 2026, $27.1 million in Q4 2025, and $29.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 4.56 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 62,953.78
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 5.83 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 14.75 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 22.66 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 910.24 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn - 26.11 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 26.11 Mn
Dec 31, 2025 27.08 Mn
Sep 30, 2025 29.06 Mn
Jun 30, 2025 29.65 Mn
Mar 31, 2025 30.50 Mn
Dec 31, 2024 31.36 Mn
Sep 30, 2024 32.33 Mn
Jun 30, 2024 33.37 Mn
Mar 31, 2024 34.50 Mn
Dec 31, 2023 35.21 Mn
Sep 30, 2023 36.38 Mn
Jun 30, 2023 37.25 Mn
Mar 31, 2023 38.98 Mn
Dec 31, 2022 40.61 Mn
Sep 30, 2022 36.97 Mn
Jun 30, 2022 38.06 Mn
Mar 31, 2022 8.95 Mn
Dec 31, 2021 9.77 Mn
Sep 30, 2021 10.18 Mn
Jun 30, 2021 10.78 Mn
Mar 31, 2021 10.98 Mn
Dec 31, 2020 12.27 Mn
Sep 30, 2020 13.36 Mn
Jun 30, 2020 14.43 Mn
Mar 31, 2020 16.06 Mn
Dec 31, 2019 17.17 Mn
Sep 30, 2019 17.43 Mn
Jun 30, 2019 17.98 Mn
Mar 31, 2019 18.45 Mn
Dec 31, 2018 10.96 Mn
Sep 30, 2018 8.38 Mn
Jun 30, 2018 7.00 Mn
Mar 31, 2018 4.86 Mn
Dec 31, 2017 5.54 Mn